Routine HbA1c screening identifies de novo (pre)diabetes mellitus in 37% of ACS patients which comes with an even higher ischemic risk compared to known diabetes mellitus
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Risk factors, risk scores, and outcomes after acute coronary syndromes
